Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Fenig

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Oncology Reports|February 22, 2001
Topical Biafine and Lipiderm for the prevention of radiation dermatitis: a randomized prospective trialE Fenig, B Brenner, A Katz, et al.
Experimental Cell Research|February 11, 1998
Basic fibroblast growth factor downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cellsQ Wang, P Maloof, H Wang, et al.
Journal of Cancer Research and Clinical Oncology|September 4, 1999
Basic fibroblast growth factor potentiates cisplatinum-induced cytotoxicity in MCF-7 human breast cancer cellsE Fenig, T Livnat, S Sharkon-Polak, et al.
Neoplasma|December 15, 2006
Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary?R Yerushalmi, A Sulkes, M Mishaeli, et al.
Breast Cancer Research and Treatment|January 5, 2002
Role of transforming growth factor beta in the growth inhibition of human breast cancer cells by basic fibroblast growth factorE Fenig, Y Kanfi, Q Wang, et al.
Cancer Research|December 15, 1994
9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and proteinM Rubin, E Fenig, A Rosenauer, et al.
British Journal of Cancer|May 5, 2005
Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell linesO Uziel, E Fenig, J Nordenberg, et al.
Cancer|April 3, 2001
Second neoplasms in patients with Merkel cell carcinomaB Brenner, A Sulkes, E Rakowsky, et al.
Cancer Chemotherapy and Pharmacology|February 9, 2000
Gemcitabine in soft tissue or bone sarcoma resistant to standard chemotherapy: a phase II studyO Merimsky, I Meller, G Flusser, et al.
The British Journal of Dermatology|August 9, 2016
Paediatric primary cutaneous marginal zone B-cell lymphoma: does it differ from its adult counterpart?I Amitay-Laish, M Tavallaee, J Kim, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Oncology Reports|February 22, 2001
Topical Biafine and Lipiderm for the prevention of radiation dermatitis: a randomized prospective trialE Fenig, B Brenner, A Katz, et al.
Experimental Cell Research|February 11, 1998
Basic fibroblast growth factor downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cellsQ Wang, P Maloof, H Wang, et al.
Journal of Cancer Research and Clinical Oncology|September 4, 1999
Basic fibroblast growth factor potentiates cisplatinum-induced cytotoxicity in MCF-7 human breast cancer cellsE Fenig, T Livnat, S Sharkon-Polak, et al.
Neoplasma|December 15, 2006
Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary?R Yerushalmi, A Sulkes, M Mishaeli, et al.
Breast Cancer Research and Treatment|January 5, 2002
Role of transforming growth factor beta in the growth inhibition of human breast cancer cells by basic fibroblast growth factorE Fenig, Y Kanfi, Q Wang, et al.
Cancer Research|December 15, 1994
9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and proteinM Rubin, E Fenig, A Rosenauer, et al.
British Journal of Cancer|May 5, 2005
Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell linesO Uziel, E Fenig, J Nordenberg, et al.
Cancer|April 3, 2001
Second neoplasms in patients with Merkel cell carcinomaB Brenner, A Sulkes, E Rakowsky, et al.
Cancer Chemotherapy and Pharmacology|February 9, 2000
Gemcitabine in soft tissue or bone sarcoma resistant to standard chemotherapy: a phase II studyO Merimsky, I Meller, G Flusser, et al.
The British Journal of Dermatology|August 9, 2016
Paediatric primary cutaneous marginal zone B-cell lymphoma: does it differ from its adult counterpart?I Amitay-Laish, M Tavallaee, J Kim, et al.
Pageof 6